Congenital Toxoplasmosis in Brazil: A Document Analysis of Government Guidelines for the Prescription and Medicine Use
DOI:
https://doi.org/10.17696/2318-3691.31.01.2025.227Keywords:
Congenital Toxoplasmosis, Pharmacological Treatment, BrazilAbstract
Introduction: Congenital toxoplasmosis can result in severe clinical manifestations and long-term complications in newborns. Standard treatment typically comprises a combination of three medications, with the potential addition of a fourth temporarily. However, the lack of commercially available pediatric formulations in Brazil requires pharmacy compounding or alternative methods to adjust adult-dose tablets for neonatal use. Objective: This study aims to examine government guidelines on the prescription and use of medications for the treatment of congenital toxoplasmosis. Methods: Document analysis was used in this descriptive, qualitative, and exploratory study. Manual searches were conducted on the websites of Municipal Health Departments from all state capitals, State Health Departments, and the Ministry of Health portal. The inclusion criteria focused on documents containing guidelines for the prescription and/or use of medications for congenital toxoplasmosis. Medication information was compiled into a spreadsheet, detailing the source and specific government guidelines related to the prescription and/or use of medications for congenital toxoplasmosis. Results: The initial search yielded 1,640 documents. After screening, 1,615 were excluded based on the titles; 25 for detailed analysis were investigated. Of these, only five met the inclusion criteria. While all included documents provided information on the therapeutic regimen and dosage, only one addressed guideline for adapting adult tablets for newborns. This underscores the lack of relevant guidelines for the rational use of medicines and the need to ensure the expected therapeutic outcomes. Conclusion: This study underscores the urgency of establishing clearer and more comprehensive guidelines regarding the appropriate use of medications for treating toxoplasmosis in newborns in Brazil.
References
1. 1. Cantey PT, Montgomery SP, Straily A. Neglected parasitic infections: what family physicians need to know-A CDC Update. Am Fam Physician. 2021;104(3):277-87.
2. Ministério da Saúde. Toxoplasmose [Internet]. Ministério da Saúde. [cited 2025 Jan 28]. Available from: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/t/toxoplasmose/toxoplasmose
3. U.S. Centers for Disease Control and Prevention - CDC. Toxoplasmosis: causes and how it spreads [Internet]. CDC; 2024 [cited 2024 Sept 11]. Available from: https://www.cdc.gov/toxoplasmosis/causes/index.html
4. Hajj RE, Tawk L, Itani S, Hamie M, Ezzeddine J, El Sabban M, et al. Toxoplasmosis: current and emerging parasite druggable targets. Microorganisms. 2021;9(12):2531. doi:10.3390/microorganisms9122531.
5. Lima Bessa G, Almeida Vitor RW, Martins-Duarte ES. Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations. Parasitol Res. 2021;120(9):3065-76. doi:10.1007/s00436-021-07282-w.
6. U.S. Centers for Disease Control and Prevention - CDC. Toxoplasmosis. About Toxoplasmosis [Internet]. CDC; 2024 [cited 2024 Sept 11]. Available from: https://www.cdc.gov/toxoplasmosis/about/index.html
7. Bahia-Oliveira L, Gomez-Marin J, Shapiro K. Toxoplasma gondii. In: Rose JB, Jiménez Cisneros B, editors. Water and Sanitation for the 21st Century: health and microbiological aspects of excreta and wastewater management (Global Water Pathogen Project) [Internet]. Michigan State University: UNESCO; 2017 [cited 2023 Jan 123]. Available from: https://www.waterpathogens.org/book/toxoplasma-gondii
8. Strang AGGF, Ferrari RG, Rosário DK, Nishi L, Evangelista FF, Santana PL, et al. The congenital toxoplasmosis burden in Brazil: systematic review and meta-analysis. Acta Trop. 2020;211:105608. doi:10.1016/j.actatropica.2020.105608.
9. Elbez-Rubinstein A, Ajzenberg D, Dardé ML, Cohen R, Dumètre A, Yera H, et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis. 2009;199(2):280-5. doi:10.1086/595793.
10. Campos FA, Andrade GMQ, Lanna APS, Lage BF, Assumpção MVM, Pinto JA. Incidence of congenital toxoplasmosis among infants born to HIV-coinfected mothers: case series and literature review. Braz J Infect Dis. 2014;18(6):609-17. doi:10.1016/j.bjid.2014.05.008.
11. Bahia-Oliveira LMG, Jones JL, Azevedo-Silva J, Alves CCF, Oréfice F, Addiss DG. Highly endemic, waterborne Toxoplasmosis in North Rio de Janeiro State, Brazil. Emerg Infect Dis. 2003;9(1):55-62. doi:10.3201/eid0901.020160.
12. Shapiro K, Bahia-Oliveira L, Dixon B, Dumètre A, Wit LA, VanWormer E, et al. Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food. Food Waterborne Parasitol. 2019;15:e00049. doi:10.1016/j.fawpar.2019.e00049.
13. Ministério da Saúde. DATASUS. TABNET [Internet]. Ministério da Saúde; 2024 [cited 2024 Sept 11]. Available from: https://datasus.saude.gov.br/informacoes-de-saude-tabnet/
14. Bahia-Oliveira LMG, Liborio-Neto AO, Dudus MM. Microcefalia por toxoplasmose congênita em tempos de epidemia por Zika vírus no Brasil. Sci Medica. 2018;28(2):29527. doi:10.15448/1980-6108.2018.2.29527.
15. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz. 2009;104(2):320-44. doi:10.1590/S0074-02762009000200029.
16. Ministério da Saúde. Secretaria de Vigilância em Saúde. Protocolo de notificação e investigação: toxoplasmose gestacional e congênita [Internet]. Brasília, DF: Ministério da Saúde; 2018 [cited 2024 Sept 11]. 38 p. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_notificacao_investigacao_toxoplasmose_gestacional_congenita.pdf
17. Ministério da Saúde. Secretaria de Atenção Primária à Saúde. Manual de gestação de alto risco [Internet]. Brasília, DF: Ministério da Saúde; 2022 [cited 2024 Sept 11]. 694 p. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/manual_gestacao_alto_risco.pdf
18. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Comissão Nacional de Incorporação de Tecnologia no SUS. Ampliação do uso do teste do pezinho para a detecção da toxoplasmose congênita [Internet]. Brasília, DF: Ministério da Saúde; 2020 [cited 2024 Sept 11]. 90 p. Available from: https://docs.bvsalud.org/biblioref/2020/11/1129148/relatorio_teste_pezinho_deteccao_toxoplasmose_congenita_516_20_EKyBvCw.pdf
19. Ministério da Saúde. Secretaria de Atenção Diária à Saúde. Nota Técnica no 100/2022-CGPAM/DSMI/SAPS/MS [Internet]. 2023 [cited 2024 Sept 11]. 14. p. Available from: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/t/toxoplasmose/arquivos/diretriz-nacional-para-a-conduta-clinica-diagnostico-e-tratamento-da-toxoplasmose-adquirida-na-gestacao-e-toxoplasmose-congenita
20. Flick U. Uma introdução à pesquisa qualitativa. Porto Alegre: Bookman; 2009.
21. Ministério da Saúde, Secretaria de Atenção à Saúde. Atenção à saúde do recém-nascido: guia para os profissionais de saúde [Internet]. 2014 [cited 2024 Sept 11]. 194 p. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/atencao_saude_recem_nascido_v1.pdf
22. Secretaria de Estado da Saúde de Santa Catarina. Nota Técnica Conjunta N° 008/2019 DAPS/DIAF/DIVE/LACEN [Internet]. Secretaria de Estado da Saúde de Santa Catarina. 2020 [cited 2023 Aug 17]. Available from: https://www.saude.sc.gov.br/index.php/informacoes-gerais-documentos/atencao-basica/notas-tecnicas-ab-aps/saude-da-crianca-1/17753-nota-tecnica-conjunta-n-008-2019-daps-diaf-dive-lacen-1/file.
23. Tocantins (Estado). Secretaria da Saúde. Nota Técnica 4/2020/SES/SVS [Internet]. 2020 [cited 2023 Aug 17]. Available from: https://central.to.gov.br/download/89999
24. Paraíba (Estado). Secretaria de Estado da Saúde. Nota Técnica n°01/2020 [Internet]. 2020 [cited 2023 Aug 17]. Available from: https://paraiba.pb.gov.br/diretas/saude/arquivos-1/vigilancia-em-saude/nota-tecnica-toxoplasmose-gevs-e-geas.pdf
25. São Paulo. Secretaria Municipal da Saúde. Nota Técnica Conjunta N° 02/2021 DVE/Coordenadoria de Vigilância em Saúde. Coordenadoria de Atenção Básica. Orientações para dispensação de medicamentos para casos de Toxoplasmose com indicação de tratamento [Internet]. São Paulo: Secretaria Municipal da Saúde; 2021 [cited 2024 Sept 11]. Available from: https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/nota_tecnica_conjunta_02_2021_toxoplasmose_04_01_2023.pdf
26. Costa BSR, Nascimento LP, Amorim MVP, Gomes APB, Veríssimo LM. Stability of extemporaneous sulfadiazine oral suspensions from commercially available tablets for treatment of congenital toxoplasmosis. Trop Med Int Health. 2020;25(3):364-72. doi:10.1111/tmi.13354.
27. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Resolução-RDC No 67, de 8 de outubro de 2007. Dispõe sobre boas práticas de manipulação de preparações magistrais e oficinais para uso humano em farmácias [Internet]. Ministério da Saúde; 2007 [cited 2024 Sept 11]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2007/rdc0067_08_10_2007.html
28. Schwenk HT, Khan A, Kohlman K, Bertaina A, Cho S, Montoya JG, et al. Toxoplasmosis in pediatric hematopoietic stem cell transplantation patients. Transplant Cell Ther. 2021;27(4):292-300. doi:10.1016/j.jtct.2020.11.003.
29. Nair KV, Gillon J, Ferguson A. Corticosteroid treatment increases parasite numbers in murine giardiasis. Gut. 1981;22(6):475-80. doi:10.1136/gut.22.6.475.
30. Munck A, Guyre PM. Glucocorticoids and immune function. In: Psychoneuroimmunology. 2nd ed. San Diego: Academic Press; 1991. p. 447-74.
31. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240(4851):516-8. doi:10.1126/science.3128869.
32. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, Wallon M, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277. doi:10.1371/journal.pntd.0000277.
33. Shwab EK, Saraf P, Zhu XQ, Zhou DH, McFerrin BM, Ajzenberg D, et al. Human impact on the diversity and virulence of the ubiquitous zoonotic parasite Toxoplasma gondii. Proc Natl Acad Sci USA. 2018;115(29):E6956-63. doi:10.1073/pnas.1722202115.
34. World Health Organization - WHO. Promoting rational use of medicines: core components [Internet]. Geneva: WHO; 2002 [Internet]. Available from: https://iris.who.int/bitstream/handle/10665/67438/WHO_EDM_2002.3.pdf
35. Brasil. [Constituição (1988)]. Constituição da República Federativa do Brasil [Internet]. Brasília, DF: Senado Federal; 1988 [cited 2024 Sept 14]. Available from: http://www.planalto.gov.br/ccivil_03/constituicao/constituicao.htm
36. Brasil, Lei nº 8080, de 19 de setembro de 1990. Dispõe sobre as condições para a promoção, proteção e recuperação da saúde, a organização e o funcionamento dos serviços correspondentes e dá outras providências [Internet]. Diário Oficial [da] União. 1990 Sept 20.
37. Ministério da Saúde. Portaria no 3916/MS/GM, de 30 de outubro de 1998. Aprova a Política Nacional de Medicamentos [Internet]. Brasília, DF: Ministério da Saúde; 1998 [cited 2024 Sept 14]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/1998/prt3916_30_10_1998.html
38. Ministério da Saúde. Conselho Nacional de Saúde. Resolução no 338 de 06 de maio de 2004 [Internet]. 2004 [cited 2024 Sept 14]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2004/res0338_06_05_2004.html
39. Domingues C, Jarak I, Veiga F, Dourado M, Figueiras A. Pediatric drug development: reviewing challenges and opportunities by tracking innovative therapies. Pharmaceutics. 2023;15(10):2431. doi:10.3390/pharmaceutics15102431.
40. Alday PH, Doggett JS. Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther. 2017;11:273-93. doi:10.2147/DDDT.S60973.
41. Soares JAS, Caldeira AP. Congenital toxoplasmosis: the challenge of early diagnosis of a complex and neglected disease. Rev Soc Bras Med Trop. 2019;52:e20180228. doi:10.1590/0037-8682-0228-2018.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Arquivos de Ciências da Saúde
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
